Embattled melanoma detection systems maker Mela Sciences (NSDQ:MELA) has another 180 days to get its stock price up before its share are pulled off of the Nasdaq exchange, the company announced.
MELA Sciences Inc.
Mela Sciences plans reboot with $12M financing
Mela Sciences loses CFO and 3 board members
Mela Sciences (NSDQ:MELA) did some high-level shuffling this month, announcing the resignation of chief financial officer Richard Steinhart as well as 3 of its 9 board members.
Mela Sciences takes new CEO from Johnson & Johnson, posts lackluster Q3
Listen to Mela Sciences’ Q3 2013 earnings call
Nanosphere prices $26M offering | Wall Street Beat
Nanosphere (NSDQ:NSPH) said it priced a public offering of 15 million shares at $1.75 apiece, aiming to drum up a minimum of $26.3 million for its molecular diagnostics technology.
Struggling Mela Sciences receives de-listing notice from NASDAQ
Mela Sciences (NSDQ:MELA) was warned by the NASDAQ Stock Market that it must pull its shares above $1.00 or risk being de-listed by the stock exchange.
Mela guts staff after Q2 losses force ‘restructuring’
Mela Sciences (NSDQ:MELA) shares slid 13 points on Wall Street yesterday after a devastating 2nd quarter forced the company to layoff 25% of its staff and impose an overall "restructuring of its operations."
MassDevice.com +3 | The top 3 med-tech stories for June 20, 2013
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Mela Sciences CEO resigns | Personnel Moves
Long-time Mela Sciences (NSDQ:MELA) CEO Joseph Gulfo resigned last week from his position as chief executive, president, chairman and member of the board. Gulfo had been Mela’s CEO since 2004, and company documents did not cite a reason for his resignation.
Mela Sciences boosts its coffers in Q1
Mela Sciences (NSDQ:MELA) boosted its cash position in the 1st quarter, raising $21.5 million from a combination of sources.
The Irvington, N.Y.-based company raised $15.7 million in public offerings of company stock and an additional $6 million in debt financing during the start of its fiscal year.